Dozens of medications can cause gynecomastia, the growth of breast tissue in men and boys. Drugs account for roughly 4 to 10% of all cases, and they do so through a handful of shared mechanisms: blocking testosterone, raising estrogen levels, or increasing prolactin. The most common culprits fall into a few well-defined categories, and knowing which drugs carry this risk can help you have a more informed conversation about alternatives.
How Medications Trigger Breast Growth
Male breast tissue stays dormant as long as the balance between testosterone and estrogen stays within a normal range. Medications cause gynecomastia by tipping that balance in one of three ways. Some drugs block testosterone from reaching its receptors, effectively reducing the body’s androgen signal. Others increase estrogen production or mimic estrogen directly. A third group raises prolactin, a hormone that stimulates breast tissue development.
Any of these shifts can activate the same breast tissue that estrogen stimulates in women. The result is a firm or rubbery mass beneath the nipple, sometimes tender, sometimes not. Which pattern you get depends partly on which drug is responsible.
Anti-Androgens and Prostate Medications
Anti-androgens are the single most common drug cause of gynecomastia. These medications are designed to suppress male hormones, so breast tissue growth is an expected downstream effect. Drugs used to treat prostate cancer, like GnRH agonists and direct androgen receptor blockers, carry the highest risk in this category.
Spironolactone, a blood-pressure and fluid-retention drug that also blocks androgen receptors, is a frequent offender. In one study of men taking 400 mg daily, two-thirds developed gynecomastia within 24 weeks. The breast enlargement with spironolactone is typically bilateral, painless, and dose-dependent. It also appears to alter the ratio of testosterone to estrogen in the blood. Importantly, gynecomastia from spironolactone has been shown to resolve after stopping the drug.
Hair Loss Drugs
Finasteride and dutasteride, commonly prescribed for male-pattern hair loss and enlarged prostate, work by blocking the enzyme that converts testosterone into its more potent form. This blockade reduces that potent form by 75 to 80%, but it also shunts more testosterone toward conversion into estrogen in the liver, testes, and other tissues.
The risk varies by dose. At the 1 mg daily dose used for hair loss, gynecomastia is uncommon but documented. At the 5 mg dose used for prostate enlargement, reported rates range from about 0.3% to 4.5% depending on the study. Dutasteride, which blocks both forms of the conversion enzyme, shows rates of roughly 1 to 2.3% in clinical trials.
What makes these drugs notable is that gynecomastia doesn’t always reverse after stopping them. Case reports show resolution times ranging from 2 months to well over 6 months, and some men experience incomplete or no resolution even years later. This unpredictability sets finasteride apart from many other drug causes.
Psychiatric Medications
Several psychiatric drugs cause gynecomastia by raising prolactin levels. Antipsychotics are the main concern, particularly risperidone and paliperidone, which have been identified as the most likely to trigger the condition. These medications block dopamine receptors in the brain, and since dopamine normally keeps prolactin in check, the result is a surge in prolactin that can stimulate breast tissue.
Among antidepressants, several SSRIs and related drugs appear on the list. Fluoxetine, paroxetine, and venlafaxine have all been linked to gynecomastia in published case reports, though the risk is considerably lower than with antipsychotics. Aripiprazole, a newer antipsychotic, has a notably better profile for prolactin control and gynecomastia compared to risperidone.
Heart and Blood Pressure Medications
Several cardiovascular drugs carry gynecomastia risk through varied mechanisms. Digoxin, used for heart failure, has a molecular structure similar enough to estrogen that it can directly activate estrogen receptors in breast tissue. Calcium channel blockers, including verapamil, diltiazem, nifedipine, and amlodipine, have all been reported to cause the condition, though the exact mechanism remains less clear.
ACE inhibitors like captopril and loop diuretics like furosemide are also on the list. Furosemide’s mechanism is still not well understood. Because heart failure patients often take several of these drugs simultaneously, the combined effect may raise the risk beyond what any single medication would cause alone.
Stomach Acid Medications
Cimetidine, an older heartburn drug, is one of the more thoroughly studied causes. It works as a competitive blocker of testosterone at the receptor level, binding to the same sites in prostate and other tissues where the body’s own androgens would normally attach. In one study, 5 out of 25 patients taking cimetidine for stomach symptoms developed breast swelling and nipple soreness within 4 to 9 months. Newer acid-reducing medications in the same family do not appear to carry the same risk, which is one reason cimetidine has largely fallen out of favor.
Supplements and Topical Products
Some over-the-counter products can cause gynecomastia without involving a prescription at all. Lavender oil and tea tree oil, found in shampoos, soaps, hair gels, and body lotions, have both weak estrogenic and anti-androgenic activity. A report published in the New England Journal of Medicine described three otherwise healthy prepubertal boys who developed gynecomastia that coincided with regular topical use of products containing these oils. Lab testing confirmed that both oils activate estrogen receptors and suppress androgen signaling in cell studies. In all three cases, breast growth resolved within months of stopping the products.
Marijuana, soy-heavy diets, and anabolic steroids are other non-prescription substances with documented links, though the strength of evidence varies.
What Happens After Stopping the Drug
Gynecomastia often resolves on its own once the responsible medication is removed, but the timeline is unpredictable. Some men see resolution within 2 to 3 months. Others wait 10 months or longer. The critical factor is how long the breast tissue has been growing. Gynecomastia present for more than about a year is unlikely to fully reverse because the breast duct tissue undergoes fibrosis, essentially scarring into a permanent state. At that point, surgery is the only effective treatment.
For cases caught earlier that don’t resolve on their own, medications that block estrogen receptors in breast tissue can help. In one documented case of persistent finasteride-related gynecomastia, six months of treatment with a selective estrogen receptor modulator produced partial resolution. But partial is the key word. Early recognition matters more than any treatment after the fact.
If you notice breast tenderness or swelling after starting a new medication, the timing is your most useful clue. Drug-induced gynecomastia typically appears weeks to months into treatment, and the connection becomes clearer when symptoms line up with a medication from one of the categories above.